S&P 5007,489.72▲0.7% Nasdaq25,373.85▲1.0% Dow52,485.03▲0.5% Russell 2K2,931.34▼0.5% 10-Yr4.75%+8bp VIX15.99−1.10 WTI$86.80▲3.8% Gold$4,098.60▼0.0% EUR/USD1.153▲0.5% BTC$62,615▼1.4% Nikkei61,867▲0.7%
At close · Fri, Jul 31, 2026
Daily Market Updates.

US Markets

Home›US Markets›M&A & Deals›AstraZeneca and Bristol-Myers Squibb tie-up talks roil…

AstraZeneca and Bristol-Myers Squibb tie-up talks roil shares

Bristol-Myers Squibb stock rose while AstraZeneca shares fell as reports of potential deal discussions spread.

Reported · Written up by our desk · M&A & Deals

MarketWatch reports that shares of AstraZeneca and Bristol-Myers Squibb moved sharply on Monday amid reports of tie-up talks.

According to MarketWatch, Bristol-Myers Squibb was jumping while AstraZeneca was slumping.

The report notes analysts are focused on the rationale for a potential combination between the two pharmaceutical companies, beyond the immediate stock reaction.

← Newer storyBithumb lays out roadmap for 2028 IPO after K-IFRS shift

More like this

US MarketsAstraZeneca shares fall on reported Bristol Myers merger talks
US MarketsAstraZeneca in talks to buy Bristol Myers Squibb in near-$400bn deal
US MarketsCapital One moves to dismiss Trump Organization account lawsuit
US MarketsBlackRock discloses 7.2% passive stake in Ondas, boosts ONDS attention
US MarketsCathie Wood trims Snowflake position after shares surge ahead of earnings

Sources

MarketWatchAstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
MarketWatchAstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.